Quantinno Capital Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.24M Buy
209,184
+2,456
+1% +$27.5K ﹤0.01% 2106
2026
Q2
$2.27M Buy
206,728
+117,425
+131% +$1.11M ﹤0.01% 1875
2026
Q1
$726K Buy
89,303
+50,498
+130% +$434K ﹤0.01% 2429
2025
Q4
$403K Buy
38,805
+9,919
+34% +$104K ﹤0.01% 2630
2025
Q3
$256K Buy
+28,886
New +$206K ﹤0.01% 2581
2025
Q2
– Sell
-12,768
Closed -$84.3K – 2609
2025
Q1
$84.3K Buy
+12,768
New +$99.5K ﹤0.01% 2058

Other funds holding KURA

Quantinno Capital Management's KURA Position: Q3 2026 in Review

Quantinno Capital Management increased its Kura Oncology (KURA) stake by 1.2% in Q3 2026, buying an estimated $27.5K and bringing the position to 209,184 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Quantinno Capital Management first reported a position in KURA in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.27M in Q2 2026. 193 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Quantinno Capital Management held 209,184 shares of Kura Oncology worth $2.24M as of Q3 2026.
  • Quantinno Capital Management bought 2,456 Kura Oncology shares in Q3 2026, an estimated $27.5K.
  • Kura Oncology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2106 holding.
  • Quantinno Capital Management first reported a position in Kura Oncology in Q1 2025 and has held it in 6 quarters since.
  • Quantinno Capital Management's Kura Oncology position peaked at $2.27M in Q2 2026.
  • 193 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.